|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's range||0.0010 - 0.0025|
|52-week range||0.0002 - 0.1450|
|Beta (5Y monthly)||1.12|
|PE ratio (TTM)||N/A|
|Earnings date||04 Mar 2024 - 08 Mar 2024|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Endo International plc (OTC: ENDPQ) announced today the launch of its new branded video series, PD Pool Hall, which aims to educate people about Peyronie's disease (PD), a men's health condition that is estimated to affect 1 in 10 men in the U.S.* and can lead to a curvature deformity of the penis when erect.
Endo International plc (OTC: ENDPQ) announced today that five new presentations related to Peyronie's disease, or PD, and XIAFLEX® (collagenase clostridium histolyticum, or CCH, injection 0.9 mg) will be shared during the Sexual Medicine Society of North America (SMSNA) annual meeting, taking place November 16-19 in San Diego.
Endo International plc (OTC: ENDPQ) today reported financial results for the third-quarter ended September 30, 2023.